Skye Bioscience, Inc. Announces Proposed Acquisition of Redx Pharma Limited
Acquiring Company
Skye Bioscience
Acquired Company
Redx Pharma
San Diego
United KingdomBiotechnologyHealthcareBiotechnologyHealth CareTherapeuticsDescription
Skye Bioscience, Inc. has proposed an acquisition of Redx Pharma Limited, aiming to enhance its position in the biotechnology sector. The transaction is subject to stockholder approvals and regulatory filings. Further details will be provided in the definitive proxy statement filed with the SEC.
Quick answer
Skye Bioscience is acquiring Redx Pharma, announced November 12, 2026. Skye Bioscience is based in San Diego, California, United States.
- How much did Skye Bioscience pay for Redx Pharma?
- The deal value was not disclosed.
- What does Skye Bioscience do?
- Skye Bioscience, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system.
- Where are Skye Bioscience and Redx Pharma based?
- Skye Bioscience is based in San Diego, California, United States. Redx Pharma is based in United Kingdom.
- Who are the decision-makers at Skye Bioscience?
- Fundz holds 1 contact at Skye Bioscience. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Nuformix proposes merger with Biovara (November 11, 2026)
- Abeona Therapeutics to Acquire APT-1011 Assets from Ellodi Pharmaceuticals (November 9, 2026)
- Acrivon Therapeutics Acquires Aqilion’s Drug Development Programs (November 6, 2026)
- Pelthos to merge with Castle Creek Biosciences (October 30, 2026)
- SpyGlass Pharma, Inc. Acquires Santen Holdings US, Inc. (October 1, 2026)
- BioAdaptives, Inc. to acquire Xycota Biosciences LLC to Expand Biotechnology Portfolio (November 4, 2026)
Who to call at Skye Bioscience, and when
When Skye Bioscience changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Skye Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Skye Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Skye Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Skye Bioscience makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Redx Pharma?
Redx Pharma was acquired by Skye Bioscience, based in San Diego. The deal was reported on November 12, 2026. Skye Bioscience, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system. Skye Bioscience is publicly traded (SKYE) and operates in Biotechnology.
When did Skye Bioscience acquire Redx Pharma?
Skye Bioscience's acquisition of Redx Pharma was reported on November 12, 2026. Skye Bioscience, Inc. has proposed an acquisition of Redx Pharma Limited, aiming to enhance its position in the biotechnology sector. The transaction is subject to stockholder approvals and regulatory filings. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Redx Pharma do?
Redx Pharma is a biotechnology company focused on developing treatments for cancer and fibrotic diseases. The company specializes in small molecule therapeutics. Its innovative approach aims to advance precision medicine. It is privately held, operating in Biotechnology, and is based in United Kingdom.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.